Myos Rens Technology (MYOS) Nearly Doubles Due To Net Revenues Increase 104%

Through six months MYOS RENS (NASDAQ: MYOS) grew 104% despite the lockdown and diving economy. Therefore, MYOS rockets more than 90% in premarket, eventually expected to surpass $3 barrier today.

Being focused on muscle health Myos Rens manages to earn customers with the aid of a narrow niche that has not many players yet. Other products may be added to the innovative line of Myos Rens with a creative approach. Hence, its revenue might grow higher.

Operating expenses fell 17% within 6 months period, perhaps laying off some employees helped a lot. However, upcoming good business days may require hiring personnel to smooth routine operations.

The stock is awesome for risk lovers and weekly trading speculators. Long term buyers are advised to stay away for now as the EPS didn’t recover yet.

Alex Krakowsky

Editor in Chief. Living in the era of dynamic tech change Alex decided to stay tuned in changes that make any person find comfort and adapt to new devices. Furthermore, gaming became his passion for spending leisure time with his close ones. Although, he has a degree in Business Administration (majoring in Finance) writing for technology and as well as finance has been one of the precious aspects of his life